Sir Chris is the founder and Chairman of Arthurian Life Sciences. He is a renowned scientist and highly successful entrepreneur with numerous prestigious awards and medals for his work over the last 30 years. He has created 11 successful academic spin-outs and founded notable companies such as Chiroscience, Celsis, Biovex, ReNeuron, Vectura and Merlin Biosciences Ltd. He directed the raising of approximately $450 million for Merlin Biosciences Funds and $2.6 billion from disposals including the sale of BioVex Group, Inc to Amgen Inc and Piramed Limited to Roche Group. Through Merlin Ventures Limited, he co-founded and advised Biotech Growth Trust Plc and Arakis Limited, one of the companies developed by Sir Chris which was sold to Sosei Co. Ltd for $187 million. Sir Chris has founded multiple listed companies with a collective market cap (as at the end of April 2016) of around $2.4 billion. Appointed OBE in 1995 for services to medical bioscience, he was then knighted in 2001 for services to bioscience and enterprise.
Professor Sir Christopher Evans, OBE.